Browse EX-10 agreements

Series B September 30 Triggering Event Waiver | 1 Waiver of September 30 2026 Triggering Event Series B Convertible Preferred Stock This Waiver (“Waiver”) is executed and delivered by the undersigned holder (the “Holder”) in favor of Nauticus Robotics, Inc., a Delaware corporation (the “Company”), with respect to the Company’s Series B Convertible Preferred Stock (the “Preferred Shares”). This Waiver relates to the Certificate of Designations of Rights and Preferences of Series B Convertible Preferred Stock of the Company, as amended or supplemented and in effect on the Effective Date (the “Certificate of Designations”). Capitalized terms not otherwise defined herein have the meanings given in the Certificate of Designations. 1. Waiver of Specified Event. Pursuant to Sections 5(a) and 22 of the Certificate of Designations, the Holder hereby irrevocably waives, with respect to the Preferred Shares, the occurrence and continuance of the Triggering Event described in Section 5(a)(xv) arising solely because any Preferred Shares remain outstanding on or after September 30, 2026 (the “Spec

…

ADOPTION AGREEMENT

DEFERRED COMPENSATION PROGRAM

The undersigned Company acting on behalf of itself and each Participating Employer, having been duly advised by its own counsel as to the legal and tax consequences of adopting this Nonqualified Deferred Compensation Program (the “Program”) and having determined that adoption of this unfunded, nonqualified deferred compensation program will enable the Company to attract and retain key personnel, HEREBY ADOPTSthis Adoption Agreement and the attached base Program document (referred to together herein as the “Program”), subject to the following terms, conditions and elections, all of which are integral parts of the Program adopted hereby:

Company Name: _Hyliion Holdings Corp.

Company Address: 1202 BMC Dr, Suite 100, Cedar Park, TX 78613

Program Name: _Hyliion Deferred Compensation Plan

Effective Date of the Program: September 28, 2026

Participating Employers: Hyliion Inc.

Record Keeper Name: The Nolan Financial Group

Record Keeper Address: 6720-B Rockledge Drive, Suite 140, Bethesda, MD 2081

…

FIFTH ADDENDUM TO THE TERM LOAN FACILITY AGREEMENT

Between

ASP ISOTOPES INCORPORATED

("ASPI")

and

ASP ISOTOPES SOUTH AFRICA PROPRIETARY LIMITED

("Lender")

and

RENERGEN LIMITED

("Borrower")

each hereinafter referred to individually as a Party and collectively as the Parties.

---

Table of Contents

Table of Contents
	1.	DEFINITIONS AND INTERPRETATION	3
	2.	INTRODUCTION	3
	3.	AMENDMENT	4
	4.	CONFLICT	4
	5.	COUNTERPARTS	4
	6.	GENERAL	4
	7.	SIGNATURE	5

2

---

WHEREBY the Parties agree as follows -

1.

…

Nicholas M. Mitchell

Via E-mail

September22, 2026

Dear Nick,

Re: LETTER OF APPOINTMENT

We have pleasure in confirming the terms and conditions under you will continue to be employed in the position ofChief Operating Officer at Renergen Limited (or any successor corporation thereto) (the Company). This LOA and the Conditions (each, as defined below) shall supersede and replace, effective as of the date hereof (Effective Date), any and all prior or contemporaneous agreements between the parties with regard to the subject matter contained herein.

Background:

…

THIS EMPLOYMENT AGREEMENT is made on 18th of August 2026

BETWEEN:

(1)

NOBLE AFRICA LLC, a Delaware limited liability company, whose business address is at 2200 Ross Avenue, Suite 4575E, Dallas, TX 75201, Untied States (the “Company”/ “we”/ “us”), and

(2)

JEREMY PATULLOwith an address of Studio House, The Street, Rotherwick, Hook, RG27 9BG, United Kingdom (“Executive”/ “you”).

IT IS AGREEDas follows:

Background:

The Company is a newly formed, wholly-owned subsidiary of ASP Isotopes Inc., a Delaware corporation (“ASPI”). Renergen Limited, a company incorporated under the laws of the Republic of South Africa (“Renergen”), is a wholly-owned subsidiary of ASPI whose principal asset is its 94.5% equity ownership in Tetra4 Proprietary Limited (“Tetra4”). Tetra4 holds an onshore petroleum production right and engages in the production and liquefaction of natural gas and the exploration and development of helium resources at the Virginia Gas Plant located in Free State Province, South Africa.

…

SIDE LETTER AGREEMENT

May 26, 2026

Side Letter Agreement — PIPE Financing

Ladies and Gentlemen:

This Side Letter Agreement (this “Side Letter”) is entered into as of the date set forth above by and between ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), and LHE LNG Holdings LLC, a Delaware limited liability company (“Investor”), in connection with the matters set forth below. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Securities Purchase Agreement (as defined below).

RECITALS

…

FOURTH ADDENDUM TO THE TERM LOAN FACILITY AGREEMENT

Between

ASP ISOTOPES INCORPORATED

("ASPI")

and

ASP ISOTOPES SOUTH AFRICA PROPRIETARY LIMITED

("Lender")

and

RENERGEN LIMITED

("Borrower")

each hereinafter referred to individually as a Party and collectively as the Parties.

---

Table of Contents

Table of Contents
1.		DEFINITIONS AND INTERPRETATION	3
2.		INTRODUCTION	3
3.		AMENDMENT	3
4.		CONFLICT	4
5.		COUNTERPARTS	4
6.		GENERAL	4
7.		SIGNATURE	4

2

---

WHEREBY the Parties agree as follows -

1.

DEFINITIONS AND INTERPRETATION

1.1.

…

THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR UPON RECEIPT BY THE COMPANY OF AN OPINION OF COUNSEL ACCEPTABLE TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT. THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS NOTE MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES. ANY TRANSFEREE OF THIS NOTE SHOULD CAREFULLY REVIEW THE TERMS OF THIS NOTE. THE PRINCIPAL AMOUNT REPRESENTED BY THIS NOTE AND, ACCORDINGLY, THE SECURITIES ISSUABLE UPON CONVERSION HEREOF, MAY BE LESS THAN THE AMOUNTS SET FORTH ON THE FACE HEREOF, PURSUANT TO THE TERMS OF THIS NOTE.

VSEE HEALTH, INC.

Promissory Note (Settlement Note)

…

SETTLEMENT AGREEMENT AND MUTUAL RELEASE

This Settlement Agreement and Mutual Release (the “Agreement”) is entered into as of July 21, 2026 (the “Effective Date”), by and among:

VSEE Health, Inc., a Delaware corporation (“VSEE” or the “Company”);

ADI Funding LLC, a Florida limited liability company (“ADI”); and

M2B Funding Corp., a Florida corporation (“M2B”).

The Company, ADI and M2B are sometimes referred to individually as a “Party” and collectively as the “Parties.”

RECITALS

…

THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR UPON RECEIPT BY THE COMPANY OF AN OPINION OF COUNSEL ACCEPTABLE TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT. THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS NOTE MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES. ANY TRANSFEREE OF THIS NOTE SHOULD CAREFULLY REVIEW THE TERMS OF THIS NOTE. THE PRINCIPAL AMOUNT REPRESENTED BY THIS NOTE AND, ACCORDINGLY, THE SECURITIES ISSUABLE UPON CONVERSION HEREOF, MAY BE LESS THAN THE AMOUNTS SET FORTH ON THE FACE HEREOF, PURSUANT TO THE TERMS OF THIS NOTE.

VSEE HEALTH, INC.

Promissory Note (Settlement Note)

…

FORM OF PRE-FUNDED WARRANT
TO PURCHASE COMMON SHARES
AKANDA CORP.

** **

Warrant Shares: [●]	Initial Exercise Date: [●]

** **

THIS PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES (the “Warrant”) certifies that, for value received, [●] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”), but not thereafter, to subscribe for and purchase from Akanda Corp., a Canadian corporation incorporated under the *Business Corporations Act *(Ontario) (the “Company”), up to [●] common shares, no par value per share (the “Common Shares”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

…

Aethlon Medical, Inc.

** **

2020 Equity Incentive Plan

** **

** **

Adopted by the Board of Directors: February 6, 2020

** **

Approved by the Stockholders: September 15, 2020

Amended by the Board: March 24, 2022

Amended by the Board: July 15, 2022

** **

Approved by the Stockholders: September 15, 2022

** **

Amended by the Board: August 6, 2024

** **

Approved by the Stockholders: September 27, 2024

Amended by the Board: December 3, 2025

Approved by the Stockholders: February 19, 2026

Amended by the Board: August 11, 2026

Approved by the Stockholders: October 1, 2026

TABLE OF CONTENTS

…